Vizsgálati helyszín
Syrentis Clinical Research
Santa Ana, California 92705, Egyesült ÁllamokMég nincs intézményhez kötve
- 15futó vizsgálat
- 20lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 36 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis22 vizsgálat
- 2. fázis7 vizsgálat
- 1/2. fázis1 vizsgálat
- Állapot
- Lezárult14 vizsgálat
- Fut, nem toboroz10 vizsgálat
- Leállították6 vizsgálat
- Toboroz4 vizsgálat
- Meghívásos bevonás1 vizsgálat
- Felfüggesztve1 vizsgálat
- Fő szponzor
- Janssen Research & Development, LLC5 vizsgálat
- Eli Lilly and Company4 vizsgálat
- Hoffmann-La Roche3 vizsgálat
- Biogen2 vizsgálat
- Cassava Sciences, Inc.2 vizsgálat
- és még 17
Futó vizsgálatok
Toboroz
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
NCT07717411· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
NCT07602582· 3. fázis· Eli Lilly and Company· Forrás
Contact: John Duffy (principal investigator)
Fut, nem toboroz
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
NCT07169578· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
NCT07177352· 3. fázis· Hoffmann-La Roche· Forrás
Fut, nem toboroz
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
NCT06653153· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
NCT06223360· 2. fázis· Weill Medical College of Cornell University· Forrás
Meghívásos bevonás
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
NCT06245031· Cognito Therapeutics, Inc.· Forrás
Fut, nem toboroz
A Study to Evaluate Efficacy and Safety of Intravenous Sabirnetug in Participants With Early Alzheimer's Disease (ALTITUDE-AD)
NCT06335173· 2. fázis· Acumen Pharmaceuticals· Forrás
Toboroz
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
NCT06189963· 1/2. fázis· NKGen Biotech, Inc.· Forrás
Contact: Nikole Bo
Fut, nem toboroz
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
NCT04838301· 2. fázis· University of Arizona· Forrás
Fut, nem toboroz
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
NCT05757869· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
NCT05711940· 3. fázis· COMPASS Pathways· Forrás
Fut, nem toboroz
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
NCT05030428· 3. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
NCT05026866· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
NCT04437511· 3. fázis· Eli Lilly and Company· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
NCT06785012· 2. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment With 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
NCT06810050· 2. fázis· CAGE Bio Inc.· Forrás
Toboroz
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
NCT06559306· 3. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS
NCT05996575· Kernel· Forrás
Lezárult
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
NCT05615220· 3. fázis· Emalex Biosciences Inc.· Forrás
Lezárult
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
NCT05637801· Cognito Therapeutics, Inc.· Forrás
Leállították
Open-label Extension for Phase 3 Clinical Trials of Simufilam
NCT05575076· 3. fázis· Cassava Sciences, Inc.· Forrás
Lezárult
Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder
NCT05536414· 2. fázis· Otsuka Pharmaceutical Development & Commercialization, Inc.· Forrás
Lezárult
A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
NCT05455684· 3. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
Identification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)
NCT05364307· Global Alzheimer's Platform Foundation· Forrás
Leállították
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
NCT05310071· 3. fázis· Biogen· Forrás
Lezárult
Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease
NCT04994483· 3. fázis· Cassava Sciences, Inc.· Forrás
Lezárult
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
NCT04777396· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
NCT04777409· 3. fázis· Novo Nordisk A/S· Forrás
Leállították
Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
NCT04951284· Novoic Limited· Forrás
Lezárult
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant
NCT04533529· 3. fázis· Janssen Research & Development, LLC· Forrás
Leállították
A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
NCT04241068· 3. fázis· Biogen· Forrás
Toboroz
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
NCT03887715· LivaNova· Forrás
Contact: Laura Yates, BSN
Lezárult
Memory Improvement Through Nicotine Dosing (MIND) Study
NCT02720445· 2. fázis· University of Southern California· Forrás
Leállították
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
NCT02446132· 3. fázis· Otsuka Pharmaceutical Development & Commercialization, Inc.· Forrás
Hibát jelzek